EBITDA Margin analysis of TherapeuticsMD Inc, FY Ratio 99.33

Loading ...

EBITDA Margin ratio Analysis of TherapeuticsMD Inc - Deep Dive

Birds's Eye

Fundamental Analysis of TherapeuticsMD Inc

WARN : Please note that some of the values may not be in base currency

Latest FY EBITDA Margin

Period Ending - Dec-23

99.33

Excellent EBITDA Margin

Period Ending - Dec-22

30.48

Very Good EBITDA Margin

Growth

225.83 %

Trailing Twelve Months EBITDA Margin

Period Ending - Dec-23

-562.47

Very Poor EBITDA Margin

Most recent Quarter EBITDA Margin

Period Ending - Mar-24

-215.97

Very Poor EBITDA Margin

EBITDA Margin Analysis of TherapeuticsMD Inc

Ebitda Margin Ratio of TherapeuticsMD Inc with value of -562.47 means that its operating expenses are Higher in relation to total revenue in trailing twelve months.
Ebitda Margin Ratio of TherapeuticsMD Inc with value of -215.97 means that its operating expenses are Higher in relation to total revenue in latest Quarter ending on Mar-24.
EBITDA Margin Ratio of TXMD rose handsomely by 225.83 % this year.
EBITDA Margin Ratio of TXMD trending up for at least three Years.
EBITDA Margin Ratio with value of -316.98 was lowest in Year Dec-19 in last Five Years.
Latest EBITDA Margin Ratio with value of 99.33 is Greater than Average EBITDA Margin of -115.09 in last five years.
Ebitda Margin of TherapeuticsMD Inc is negative because of negative EBITDA in Trailing Twelve Months ended on Mar-24.

Other EBITDA Margin Related Info of TXMD that may interest you.

TherapeuticsMD Inc Overview

Code	Price	Previous Price	Price Change	Sector
TXMD	1.99	2.03	1.97 %	Drug Manufacturers-Specialty & Generic

Fundamental Analysis Technical Analysis

Defination of EBITDA Margin

EBITDA Margin is the profitability ratio that measures a company's earnings before interest, taxes, depreciation, and amortization as a percentage of revenue. EBITDA is the abbreviation for Earnings before Interest, Taxes, Depreciation, and Amortization. more ..

EBITDA Margin Related Ratios

NetProfitMargin

ReturnOnEquity

Tsr Profitability Index


Poor Profitability Stock

FY - Historical EBITDA Margin of TherapeuticsMD Inc

Period	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17
EBITDA Margin	99.33	30.48	-155.73	-232.57	-316.98	-792.86	-457.23
Change	225.83 %	119.58 %	33.04 %	26.63 %	60.02 %	-73.41 %	1.38 %

You are view first 7 Records. Log in to view all 33 in Premium view

FY Chart of EBITDA Margin of TherapeuticsMD Inc

Note : All Data Generated at the End of Trading Hours (EOD Data)